1. Griewahn, Laura, Müller-Foxworth, Madeleine, Peintner, Lukas, Charvet, Céline, Maurer, Ulrich. 2023. SPATA2 restricts OTULIN-dependent LUBAC activity independently of CYLD. In Cell reports, 42, 111961. doi:10.1016/j.celrep.2022.111961. https://pubmed.ncbi.nlm.nih.gov/36640323/
2. Kupka, Sebastian, De Miguel, Diego, Draber, Peter, Rittinger, Katrin, Walczak, Henning. 2016. SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. In Cell reports, 16, 2271-80. doi:10.1016/j.celrep.2016.07.086. https://pubmed.ncbi.nlm.nih.gov/27545878/
3. Schlicher, Lisa, Wissler, Manuela, Preiss, Florian, Dengjel, Joern, Maurer, Ulrich. 2016. SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death. In EMBO reports, 17, 1485-1497. doi:. https://pubmed.ncbi.nlm.nih.gov/27458237/
4. Wei, Ran, Xu, Lily Wen, Liu, Jianping, Yuan, Junying, Pan, Heling. 2017. SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination. In Genes & development, 31, 1162-1176. doi:10.1101/gad.299776.117. https://pubmed.ncbi.nlm.nih.gov/28701375/
5. Ji, Hongbo, Zhang, Lu, Zou, Man, Yuan, Zhiyong, Wu, Zhiqiang. 2023. SPATA2 suppresses epithelial-mesenchymal transition to inhibit metastasis and radiotherapy sensitivity in non-small cell lung cancer via impairing DVL1/β-catenin signaling. In Thoracic cancer, 14, 969-982. doi:10.1111/1759-7714.14828. https://pubmed.ncbi.nlm.nih.gov/36814090/
6. Elliott, Paul R, Leske, Derek, Hrdinka, Matous, Komander, David, Gyrd-Hansen, Mads. 2016. SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. In Molecular cell, 63, 990-1005. doi:10.1016/j.molcel.2016.08.001. https://pubmed.ncbi.nlm.nih.gov/27591049/
智鼠故事 
